Difficulty: Medium
Average Score: 86%
Practice
Resistance in many Gram negative bacteria is the result of the production of extended spectrum betalactamases (ESBL). Which of the following classes of antibiotics is not inactivated by ESBL?
Correct answer
C
Rationale
The correct answer is C) Glycopeptides. Extended spectrum beta-lactamases (ESBL) are enzymes produced by certain bacteria that confer resistance to beta-lactam antibiotics. Glycopeptides, such as vancomycin and teicoplanin, are not beta-lactam antibiotics, so they are not inactivated by ESBL. This is because glycopeptides have a different mechanism of action compared to beta-lactam antibiotics, making them effective against ESBL-producing bacteria.
A) Trimethoprim is a folate antagonist antibiotic and is not inactivated by ESBL. B) Aminoglycosides, like gentamicin and amikacin, are not beta-lactam antibiotics and are not affected by ESBL. D) Quinolones, such as ciprofloxacin and levofloxacin, are also not beta-lactam antibiotics and are not inactivated by ESBL.
Educationally, understanding the mechanisms of antibiotic resistance, such as ESBL production, is crucial for healthcare professionals, especially those working in infection control and antimicrobial stewardship. Knowing which classes of antibiotics are affected by specific resistance mechanisms can help in selecting appropriate antibiotics for treating infections caused by multidrug-resistant bacteria, ultimately improving patient outcomes and reducing the spread of resistant strains.
A) Trimethoprim is a folate antagonist antibiotic and is not inactivated by ESBL. B) Aminoglycosides, like gentamicin and amikacin, are not beta-lactam antibiotics and are not affected by ESBL. D) Quinolones, such as ciprofloxacin and levofloxacin, are also not beta-lactam antibiotics and are not inactivated by ESBL.
Educationally, understanding the mechanisms of antibiotic resistance, such as ESBL production, is crucial for healthcare professionals, especially those working in infection control and antimicrobial stewardship. Knowing which classes of antibiotics are affected by specific resistance mechanisms can help in selecting appropriate antibiotics for treating infections caused by multidrug-resistant bacteria, ultimately improving patient outcomes and reducing the spread of resistant strains.